FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116988228> ?p ?o ?g. }

• W2116988228 endingPage "155" @default.
• W2116988228 startingPage "149" @default.
• W2116988228 abstract "Purpose Although American Society of Clinical Oncology guidelines discourage the use of tumor marker assessment for routine surveillance in nonmetastatic breast cancer, their use in practice is uncertain. Our objective was to determine use of tumor marker tests such as carcinoembryonic antigen and CA 15-3/CA 27.29 and associated Medicare costs in early-stage breast cancer survivors. Methods By using Surveillance, Epidemiology, and End Results-Medicare records for patients diagnosed with early-stage breast cancer between 2001 and 2007, tumor marker usage within 2 years after diagnosis was identified by billing codes. Logistic regression models were used to identify clinical and demographic factors associated with use of tumor markers. To determine impact on costs of care, we used multivariable regression, controlling for other factors known to influence total medical costs. Results We identified 39,650 eligible patients. Of these, 16,653 (42%) received at least one tumor marker assessment, averaging 5.7 tests over 2 years, with rates of use per person increasing over time. Factors significantly associated with use included age at diagnosis, diagnosis year, stage at diagnosis, race/ethnicity, geographic region, and urban/rural status. Rates of advanced imaging, but not biopsies, were significantly higher in the assessment group. Medical costs for patients who received at least one test were approximately 29% greater than costs for those who did not, adjusting for other factors. Conclusion Breast cancer tumor markers are frequently used among women with early-stage disease and are associated with an increase in both diagnostic procedures and total cost of care. A better understanding of factors driving the use of and the potential benefits and harms of surveillance-based tumor marker testing is needed." @default.
• W2116988228 created "2016-06-24" @default.
• W2116988228 creator A5001373245 @default.
• W2116988228 creator A5020805619 @default.
• W2116988228 creator A5025364402 @default.
• W2116988228 creator A5045172677 @default.
• W2116988228 creator A5046985026 @default.
• W2116988228 creator A5081974715 @default.
• W2116988228 creator A5083487516 @default.
• W2116988228 creator A5085042140 @default.
• W2116988228 creator A5088225928 @default.
• W2116988228 date "2015-01-10" @default.
• W2116988228 modified "2023-10-18" @default.
• W2116988228 title "Tumor Marker Usage and Medical Care Costs Among Older Early-Stage Breast Cancer Survivors" @default.
• W2116988228 cites W1525318852 @default.
• W2116988228 cites W1559985112 @default.
• W2116988228 cites W1714898864 @default.
• W2116988228 cites W1826672661 @default.
• W2116988228 cites W1860982588 @default.
• W2116988228 cites W1955382134 @default.
• W2116988228 cites W1965781424 @default.
• W2116988228 cites W1995999523 @default.
• W2116988228 cites W1996121381 @default.
• W2116988228 cites W2000445173 @default.
• W2116988228 cites W2031676043 @default.
• W2116988228 cites W2046028079 @default.
• W2116988228 cites W2060907634 @default.
• W2116988228 cites W2067132339 @default.
• W2116988228 cites W2107603848 @default.
• W2116988228 cites W2117305280 @default.
• W2116988228 cites W2119642155 @default.
• W2116988228 cites W2134610062 @default.
• W2116988228 cites W2140827053 @default.
• W2116988228 cites W2157358083 @default.
• W2116988228 cites W2166568742 @default.
• W2116988228 doi "https://doi.org/10.1200/jco.2014.55.5409" @default.
• W2116988228 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4279234" @default.
• W2116988228 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25332254" @default.
• W2116988228 hasPublicationYear "2015" @default.
• W2116988228 type Work @default.
• W2116988228 sameAs 2116988228 @default.
• W2116988228 citedByCount "45" @default.
• W2116988228 countsByYear W21169882282015 @default.
• W2116988228 countsByYear W21169882282016 @default.
• W2116988228 countsByYear W21169882282017 @default.
• W2116988228 countsByYear W21169882282018 @default.
• W2116988228 countsByYear W21169882282019 @default.
• W2116988228 countsByYear W21169882282020 @default.
• W2116988228 countsByYear W21169882282021 @default.
• W2116988228 countsByYear W21169882282022 @default.
• W2116988228 countsByYear W21169882282023 @default.
• W2116988228 crossrefType "journal-article" @default.
• W2116988228 hasAuthorship W2116988228A5001373245 @default.
• W2116988228 hasAuthorship W2116988228A5020805619 @default.
• W2116988228 hasAuthorship W2116988228A5025364402 @default.
• W2116988228 hasAuthorship W2116988228A5045172677 @default.
• W2116988228 hasAuthorship W2116988228A5046985026 @default.
• W2116988228 hasAuthorship W2116988228A5081974715 @default.
• W2116988228 hasAuthorship W2116988228A5083487516 @default.
• W2116988228 hasAuthorship W2116988228A5085042140 @default.
• W2116988228 hasAuthorship W2116988228A5088225928 @default.
• W2116988228 hasBestOaLocation W21169882282 @default.
• W2116988228 hasConcept C107130276 @default.
• W2116988228 hasConcept C121608353 @default.
• W2116988228 hasConcept C126322002 @default.
• W2116988228 hasConcept C143998085 @default.
• W2116988228 hasConcept C146357865 @default.
• W2116988228 hasConcept C151730666 @default.
• W2116988228 hasConcept C151956035 @default.
• W2116988228 hasConcept C195910791 @default.
• W2116988228 hasConcept C2779134260 @default.
• W2116988228 hasConcept C2781447364 @default.
• W2116988228 hasConcept C530470458 @default.
• W2116988228 hasConcept C71924100 @default.
• W2116988228 hasConcept C86803240 @default.
• W2116988228 hasConceptScore W2116988228C107130276 @default.
• W2116988228 hasConceptScore W2116988228C121608353 @default.
• W2116988228 hasConceptScore W2116988228C126322002 @default.
• W2116988228 hasConceptScore W2116988228C143998085 @default.
• W2116988228 hasConceptScore W2116988228C146357865 @default.
• W2116988228 hasConceptScore W2116988228C151730666 @default.
• W2116988228 hasConceptScore W2116988228C151956035 @default.
• W2116988228 hasConceptScore W2116988228C195910791 @default.
• W2116988228 hasConceptScore W2116988228C2779134260 @default.
• W2116988228 hasConceptScore W2116988228C2781447364 @default.
• W2116988228 hasConceptScore W2116988228C530470458 @default.
• W2116988228 hasConceptScore W2116988228C71924100 @default.
• W2116988228 hasConceptScore W2116988228C86803240 @default.
• W2116988228 hasIssue "2" @default.
• W2116988228 hasLocation W21169882281 @default.
• W2116988228 hasLocation W21169882282 @default.
• W2116988228 hasLocation W21169882283 @default.
• W2116988228 hasLocation W21169882284 @default.
• W2116988228 hasOpenAccess W2116988228 @default.
• W2116988228 hasPrimaryLocation W21169882281 @default.
• W2116988228 hasRelatedWork W1576711507 @default.
• W2116988228 hasRelatedWork W2005585032 @default.
• W2116988228 hasRelatedWork W2129863591 @default.

• next